XFOR · Company research
X4 Pharmaceuticals, Inc. Common Stock (XFOR): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 2.77 | $366,397,658 | 171302658.0 | 0.49743589743589743590 | — | — | 41.6077285941403588 | 2.3569522688383702 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.